Search - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Access content directly

Filter your results

279 Results
Domains : sdv

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells

Marc Berger , Benjamin Lebecque , Thomas Tassin , Louis-Thomas Dannus , Juliette Berger et al.
Scientific Reports, 2021, 11 (1), ⟨10.1038/s41598-021-85734-0⟩
Journal articles hal-03278034v1

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin Parry , Ignaty Leshchiner , Romain Guièze , Connor Johnson , Eugen Tausch et al.
Nature Medicine, 2023, 29 (1), pp.158-169. ⟨10.1038/s41591-022-02113-6⟩
Journal articles hal-03950358v1

Réforme de l’accès dérogatoire aux médicaments

Jacques-Olivier Bay
Bulletin du Cancer, 2022, 109 (1), pp.20-22. ⟨10.1016/j.bulcan.2021.11.008⟩
Journal articles hal-03737555v1

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

Jean‐baptiste Bossard , Jean‐baptiste Beuscart , Marie Robin , Mohamad Mohty , Fiorenza Barraco et al.
American Journal of Hematology, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
Journal articles hal-03089653v1

Characterization of the novel HLA‐B *56:76 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Gwendaline Guidicelli , Paul Rouzaire , Richard Lemal et al.
HLA: Immune Response Genetics, 2021, 98 (1), pp.66-67. ⟨10.1111/tan.14237⟩
Journal articles hal-03449232v1

Round table : impact of CAR T-cells on patient journey, local or regional organization, and follow-up

Jacques-Olivier Bay
Cell Therapy Innovation 360°, May 2019, Lyon, France
Conference papers hal-02056276v1

Accuracy of Chitotriosidase Activity and CCL18 Concentration in Assessing Type I Gaucher Disease Severity. A Systematic Review with Meta-analysis of Individual Participant Data

Tatiana Raskovalova , Patrick B. Deegan , Pramod K. Mistry , Elena Pavlova , Ruby Yang et al.
13th EWGGD Meeting, Jul 2019, Clermont-Ferrand, France
Conference poster hal-02304018v1

Traitement de première ligne de la Leucémie Myéloïde Chronique dans la « vraie vie » : Données de l’Observatoire LMC

Alexandre Janel , Sandrine Saugues , C. Lambert , Hyacinthe Johnson-Ansah , Denis Guyotat et al.
39e Congrès de la Société Française d’Hématologie, Mar 2019, Paris, France. 25 (S1), pp.172, 2019, Hématologie
Conference poster hal-02304921v1

Arrêt des Inhibiteurs de Tyrosine Kinase (ITK) pour réponse optimale dans la LMC dans la « vraie vie » et recommandations du groupe Fi-LMC

Alexandre Janel , Sandrine Saugues , C. Lambert , Hyacinthe Johnson-Ansah , Denis Guyotat et al.
39e Congrès de la Société Française d’Hématologie, Mar 2019, Paris, France. 25 (S1), pp.173, 2019, Hématologie
Conference poster hal-02304953v1

Real-World Ibrutinib Validation of the Ball Score to Predict Overall Survival: A Filo Group Study in RR CLL Patients

Loic Ysebaert , A.S. Michallet , F. Bijou , A. Clavert , A. Quinquenel et al.
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1741, 2019, Blood
Conference poster hal-02427548v1

Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma

Clémentine Sarkozy , Christiane Copie-Bergman , Diane Damotte , Susana Ben-Neriah , Barbara Burroni et al.
American Journal of Surgical Pathology, 2019, 43 (3), pp.341-351. ⟨10.1097/PAS.0000000000001198⟩
Journal articles hal-02055918v1
Image document

Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients

Marie Balsat , Sylvie Pillet , Emmanuelle Tavernier , Victoria Cacheux , Vanessa Escuret et al.
Journal of Infection, 2019, 79 (1), pp.36-42. ⟨10.1016/j.jinf.2019.05.001⟩
Journal articles hal-02299171v1

Quelle place pour l’allogreffe à l’ère des nouvelles drogues et des nouvelles approches d’immunothérapie dans les hémopathies malignes ? (SFGM-TC)

Jacques-Olivier Bay
39e Congrès de la Société Française d’Hématologie, Mar 2019, Paris, France
Conference papers hal-02124755v1

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

M. Biegstraaten , M. Cox , N. Belmatoug , M.G Berger , T. Collin-Histed et al.
Blood Cells, Molecules and Diseases, 2018, 68, pp.203 - 208. ⟨10.1016/j.bcmd.2016.10.008⟩
Journal articles hal-01672894v1

Les points chauds de l’actualité en 2017. Une sélection du comité de rédaction du Bulletin du Cancer

Stéphane Vignot , Thierry André , Christophe Caux , Carole Bouleuc , Serge Evrard et al.
Bulletin du Cancer, 2018, 105 (1), pp.6 - 14. ⟨10.1016/j.bulcan.2017.11.006⟩
Journal articles hal-01712424v1

Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial

Francoise Kraeber-Bodere , Amandine Pallardy , Hervé Maisonneuve , Loïc Campion , Anne Moreau et al.
The Lancet Haematology, 2017, 4 (1), pp.e35-e45. ⟨10.1016/S2352-3026(16)30168-5⟩
Journal articles hal-02425339v1

Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant

Anne Bergeron , Sylvie Chevret , Angela Granata , Patrice Chevallier , Laure Vincent et al.
JAMA Ophthalmology, 2017, 318 (6), pp.557-566. ⟨10.1001/jama.2017.9938⟩
Journal articles hal-01655930v1

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

Sophie Michallet , Arnaud Campidelli , Helene Lequeu , Marie-Sarah Dilhuydy , Olivier Tournilhac et al.
American Journal of Hematology, 2017, 92 (6), pp.E105 - E107. ⟨10.1002/ajh.24715⟩
Journal articles hal-01653723v1

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data

Tatiana Raskovalova , Patrick B. Deegan , Ruby Yang , Elena Pavlova , Jérôme Stirnemann et al.
Systematic Reviews, 2017, 6 (1), pp.87. ⟨10.1186/s13643-017-0483-x⟩
Journal articles hal-01655857v1

Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1

Juliette Berger , Marie Vigan , Bruno Pereira , Thu Thuy Nguyen , Roseline Froissart et al.
Clinical Pharmacokinetics, 2019, 58 (4), pp.469-482. ⟨10.1007/s40262-018-0708-8⟩
Journal articles hal-02052295v1

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study

Alexandre Morel , Josette Brière , Laurence Lamant , Michael Loschi , Corinne Haioun et al.
European Journal of Cancer, 2017, 83, pp.146 - 153. ⟨10.1016/j.ejca.2017.06.026⟩
Journal articles hal-01655967v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model

Benjamin Lebecque , Céline Bourgne , Véronique Vidal , Marc Berger
Cancers, 2021, 13 (14), pp.3587. ⟨10.3390/cancers13143587⟩
Journal articles hal-03440088v1

Characterization of the novel HLA‐DQA1 *01:39 allele by next‐generation sequencing

Steve Genebrier , Paul Rouzaire , Emeric Texeraud , Gerald Bertrand , Virginie Renac et al.
HLA: Immune Response Genetics, 2021, 98 (3), pp.240-241. ⟨10.1111/tan.14142⟩
Journal articles hal-03449390v1

Characterization of the novel HLA‐C *06:311 allele by sequencing‐based typing

Lucie Blandin , Mamy Ralazamahaleo , Marine Cargou , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 97 (6), pp.565-566. ⟨10.1111/tan.14233⟩
Journal articles hal-03449287v1

ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome

Camilla Lemvigh , Erin Michelle Parry , Stephanie Deng , Nathan Dangle , Neil Ruthen et al.
Blood, 2022, 140 (Supplement 1), pp.1807-1808. ⟨10.1182/blood-2022-162550⟩
Journal articles hal-03950370v1

Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia

Salem Bahashwan , Cécile Moluçon-Chabrot , Eric Hermet , Aurélie Ravinet , Aurore Douge et al.
American Journal of Hematology, 2019, 94 (1), pp.E32-E35. ⟨10.1002/ajh.25332⟩
Journal articles hal-01926811v1

Maladie de Gaucher

Marc Berger
4èmes Journées d’Hématologie Biologique du Grand-Est, Mar 2019, Nancy, France
Conference papers hal-02125901v1

Contribution of Chronic Myeloid Leukaemia (CML) as a Disease Model to Define and Study Clonal Heterogeneity

Marc Berger , Céline Bourgne
Advances in experimental médicine and biology, 1139, pp.171-185, 2019, ⟨10.1007/978-3-030-14366-4_10⟩
Book sections hal-02301455v1

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

Anna Patrikidou , Loïc Chaigneau , Nicolas Isambert , Kyriaki Kitikidou , Ryan Shanley et al.
BMC Cancer, 2020, 20 (1), pp.117. ⟨10.1186/s12885-020-6548-6⟩
Journal articles hal-02872774v1